Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Candace L. Jackson"'
Autor:
Candace L. Jackson, Todd Huschka, Bijan Borah, Katherine Agre, Magdi Zordok, Medhat Farwati, James Moriarty, Iftikhar J. Kullo
Publikováno v:
American Journal of Preventive Cardiology, Vol 8, Iss , Pp 100245- (2021)
Objective There is no coordinated cascade testing program for familial hypercholesterolemia (FH) in the U.S. We evaluated the contemporary cost-effectiveness of cascade genetic testing relatives of FH probands with a pathogenic variant. Methods: A si
Externí odkaz:
https://doaj.org/article/7e4f6deca497480fbc6c8e59838e5bf8
Publikováno v:
American Journal of Preventive Cardiology, Vol 6, Iss , Pp 100157- (2021)
Familial hypercholesterolemia (FH) is a relatively common autosomal dominant disorder associated with a significantly increased risk of coronary heart disease (CHD). Most (~85–90%) cases are due to pathogenic variants in the LDL-receptor gene (LDLR
Externí odkaz:
https://doaj.org/article/ac86b7f790a845deab7da4956804836f
Publikováno v:
American Journal of Preventive Cardiology, Vol 1, Iss , Pp 100002- (2020)
Objectives: Patients with severe hyperlipidemia (low-density lipoprotein-cholesterol (LDL-C) ≥190 mg/dL) have a significantly increased risk of cardiovascular disease (CVD) and are more likely to have familial hypercholesterolemia (FH). We sough
Externí odkaz:
https://doaj.org/article/1e1961392e2544b5aa26b6d5edf688e6
Autor:
Holly K. Van Houten, Candace L. Jackson, Stephen L. Kopecky, Xiaoxi Yao, Nilay Shah, Yihong Deng
Publikováno v:
Journal of Clinical Lipidology. 15:339-346
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were approved in August 2015 as an adjunct to maximally tolerated statin treatment in those with familial hypercholesterolemia (FH).To assess PCSK9 inhibitor utilization patterns and ch
Publikováno v:
American Journal of Preventive Cardiology, Vol 1, Iss, Pp 100002-(2020)
American Journal of Preventive Cardiology
American Journal of Preventive Cardiology
Objectives Patients with severe hyperlipidemia (low-density lipoprotein-cholesterol (LDL-C) ≥190 mg/dL) have a significantly increased risk of cardiovascular disease (CVD) and are more likely to have familial hypercholesterolemia (FH). We sought
Autor:
Medhat Farwati, Todd R. Huschka, Candace L. Jackson, Katherine Agre, James P. Moriarty, Bijan J. Borah, Magdi Zordok, Iftikhar J. Kullo
Publikováno v:
American Journal of Preventive Cardiology, Vol 8, Iss, Pp 100245-(2021)
American Journal of Preventive Cardiology
American Journal of Preventive Cardiology
Objective There is no coordinated cascade testing program for familial hypercholesterolemia (FH) in the U.S. We evaluated the contemporary cost-effectiveness of cascade genetic testing relatives of FH probands with a pathogenic variant. Methods A sim
Autor:
Marcelo F. Di Carli, Jon Hainer, Mary Cawley, Mattheus Ramsis, Amber Fatima, David W Biery, Patrycja Galazka, Sanjay Divakaran, Petr Jarolim, Deepak L. Bhatt, Arman Qamar, Candace L. Jackson, Ersilia M. DeFilippis, Bradley Collins, Ron Blankstein, Ankur Gupta, Khurram Nasir, Josh Klein, Daniel C. Pipilas, Avinainder Singh, James L. Januzzi, Zaid Almarzooq
Publikováno v:
Journal of the American College of Cardiology. 75(9)
Type 2 myocardial infarction (MI) and myocardial injury are associated with increased short-term mortality. However, data regarding long-term mortality are lacking.This study compared long-term mortality among young adults with type 1 MI, type 2 MI,
Autor:
Nilay Shah, Stephen L. Kopecky, Xiaoxi Yao, Holly K. Van Houten, Candace L. Jackson, Yihong Deng
Publikováno v:
Journal of the American College of Cardiology. 75:1873
Familial hypercholesterolemia (FH) is an inherited disorder that causes premature cardiovascular disease (CVD). Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were approved in August 2015 as an adjunct to maximally tolerated statin
Autor:
Colby Ayers, Merlyn H. Sayers, Candace L. Jackson, M. Odette Gore, Amit Khera, Zahid A. Ahmad, Stephen J. Eason, James Z. Keeton, Darren K. McGuire
Publikováno v:
JAMA Cardiology. 4:685
Familial hypercholesterolemia is an autosomal-dominant disorder that often causes premature coronary artery disease. Unfortunately, familial hypercholesterolemia remains largely undiagnosed.To estimate the prevalence of familial hypercholesterolemia
Autor:
Nicholas Y. Tan, Peter A. Noseworthy, Adelaide M. Arruda-Olson, Candace L. Jackson, Marc Granrud
Publikováno v:
Journal of the American College of Cardiology. 73:2792
The Expert Consensus Recommendations on Criteria for the Diagnosis of Cardiac Sarcoidosis (CS) require histological evidence of non-caseating granulomas. However, the disease's patchy myocardial involvement limits the diagnostic yield of blind endomy